Page 2 - Thyrocare Technologies

Exploring windows to enhance shareholder value: Thyrocare Technologies

Thyrocare's market capitalisation is around Rs 6,916 crore. The deal thus could be for a shareholding in the firm

Nifty Pharma index hits new high; Aurobindo, Dr Reddy's gain over 3%

Marksans Pharma and Novartis India from the S&P BSE Healthcare index zoomed 20 per cent each

Testing recovery gains factored in Thyrocare Technologies stock

Margin pressures and valuations would limit major upsides

Surprise amid pandemic: Firms across sectors beat Q2 earnings expectations

Most brokerages have revised upwards their earnings estimates, not only for FY21, but also for FY22

Dr Lal PathLabs, Thyrocare slip on profit booking on Covid vaccine optimism

From March lows, the stock price of Thyrocare Technologies has been more-than-tripled and of Dr Lal PathLabs more-than-doubled on the BSE

Thyrocare rallies 10%, hits record high on expectation of strong Q2 results

Earlier this month, the company reported nearly 37 per cent year-on-year and over 100 per cent sequential growth in aggregate revenue for Q2FY21

Diagnostics players post healthy returns on quick rebound in business

Sharp rise in non-Covid business and strong revenue growth indicated by Thyrocare, Metropolis prop up sentiment

Thyrocare, Dr Lal PathLabs: Healthcare stocks can rally more, charts show

A new all time high shows bullish sentiment is here to stay in these stocks.

Healthcare services stocks rally; Thyrocare up 35% in 2 days post Q2 update

Thyrocare Technologies, Metropolis Healthcare and Dr. Lal PathLabs, hitting their respective record highs, were up 9 per cent to 17 per cent on the BSE in intra-day trade.

Thyrocare surges 15% on healthy revenue growth in September quarter

The stock of healthcare services provider has now surpassed its previous high of Rs 845.25 touched on August 17, 2020

Thyrocare Tech surges 5% after Co authorises Dr. A Velumani to appoint CEO

The Board has also authorised Dr. A Velumani to identify a competent candidate for the position of Managing Director, CFO, and CIO.

Thyrocare Tech, Dr Lal Path Labs surge as pvt labs to conduct Covid-19 test

That apart, national laboratories have also been allowed to carry out clinical testing of Covid-19, as the number of cases went past 400 in India.

Thyrocare Technologies hits 52-week high, surges 28% in two days

The company's normalized Ebitda grew 19 per cent year on year (YoY) at Rs 42.5 crore, while margins improved to 40 per cent compared with 37 per cent clocked in the previous year quarter

Thyrocare Technologies up 7% as board mulls share buyback proposal

Thus far in the calendar year 2018, Thyrocare had underperformed the market by falling 14% as compared to 8.6% rise in the S&P BSE Sensex till Friday.

Demand growth, market share gains for Thyrocare Technologies

Stock one of the top picks among analysts in health care space

Thyrocare eyes Rs 1,000 cr biz by 2020

Firm will expand lab centres to 25, from seven currently, and increase franchisees from 1,200 to 5,000

In debut, Thyrocare healthier than others

Health care firm's listing outshines that of Alkem and Narayana Hrudayalaya

Thyrocare Technologies makes stellar debut; up 49% at Rs 655

The stock listed at Rs 665, a 49% premium compared with its issue price of Rs 446 per equity share, on the NSE.

Thyrocare raises Rs 144 crore from anchor investors

Thyrocare has allocated 32,23,411 shares to 15 anchor investors at Rs 446 per share

Thyrocare Technologies IPO: Should you subscribe?

Here's a quick compilation of what country's top research and brokerage houses suggest